[Experimental blood platelet thrombosis in cerebral arteries. Effects of dipyridamole, ergot derivatives and antiserotonin agents].
D000818:Animals; D001792:Blood Platelets; D002539:Cerebral Arterial Diseases / Q000188:drug therapy / Q000503:physiopathology; D002536:Cerebral Arteries / Q000293:injuries; D002560:Cerebrovascular Circulation / Q000187:drug effects; D004176:Dipyridamole / Q000627:therapeutic use*; D004876:Ergot Alkaloids / Q000627:therapeutic use*; D002542:Intracranial Embolism and Thrombosis / Q000188:drug therapy*; D008784:Methysergide / Q000627:therapeutic use*; D011817:Rabbits; D012702:Serotonin Antagonists; D013927:Thrombosis / Q000503:physiopathology
D004876:Ergot Alkaloids; D012702:Serotonin Antagonists; D004176:Dipyridamole; D008784:Methysergide
Thromboses plaquettaires expérimentales dans les artères cérébrales. Effets du dipyridamole, de dérivés de l'ergot de seigle et d'antisérotonines.